Endothelial-Pericyte Crosstalk in Diabetic Stroke
糖尿病中风的内皮-周细胞串扰
基本信息
- 批准号:10400506
- 负责人:
- 金额:$ 20.48万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-06-01 至 2023-02-28
- 项目状态:已结题
- 来源:
- 关键词:AcuteAnti-Inflammatory AgentsBlood VesselsBlood capillariesBlood flowBrainCSPG4 geneCellsChronic PhaseComplementCytometryDementiaDevelopmentDiabetes MellitusDiseaseDsRedEndotheliumFemaleGPR39 geneGene Expression ProfilingHeterogeneityImpaired cognitionInflammatoryInjuryIschemiaLabelLeadMorphologyMusNational Institute of Neurological Disorders and StrokeNeuronal DysfunctionOutcomeParentsPericytesPhasePhenotypePlayProcessProliferatingRecoveryReportingResearchRoleSignal TransductionStrokeTestingTissue-Specific Gene ExpressionWorkbrain celldiabeticinsightmaleneuroinflammationnon-diabeticparent projectpost strokepost stroke cognitive impairmentpost stroke dementiapreservationpreventrepairedsingle-cell RNA sequencingstroke recoverystroke risktherapy developmenttranscriptome sequencing
项目摘要
Abstract
Work proposed in the current supplement complements research proposed in the parent NINDS R01 NS108501-
01 “Endothelial-Pericyte Crosstalk in Diabetic Stroke”. Studies in the parent R01 were focused on the acute
vascular changes that are common after diabetic stroke (i.e., microvascular no-reflow). The current supplement
will investigate the long-term cognitive impairment that follows stroke and that is also more common after diabetic
stroke (post-stroke cognitive impairment and dementia, PSCID). The parent project specifically investigated the
role of endothelial-pericyte signaling (endothelial-derived epoxyeicosatrienoates (EETs) acting on GPR39 on
peri-capillary pericytes) in microvascular no-reflow after diabetic stroke. We tested the hypothesis that
EETs/CPR39 crosstalk preserves capillary blood flow in brain after ischemia, and that diabetes reduces
microvascular endothelial EETs, leading to pericyte contraction and injury and subsequent capillary occlusion
(no-reflow). During the course of the study, we made the observation that in the delayed phase after stroke,
pericytes detach from capillaries, proliferate and migrate away from capillaries. We have also observed that
these pericytes undergo morphological transformation that is consistent with pericyte activation. Activated
pericytes have been reported to play a pro-inflammatory as well anti-inflammatory role under different disease
conditions. However, the role of pericyte activation during the chronic phase of recovery from stroke and in post-
stroke cognitive impairment under diabetic conditions is not clear. We will test the hypothesis that in normal
brain, pericyte activation promotes recovery and functional repair after stroke. Under diabetic conditions,
activated pericytes switch to a pro-inflammatory phenotype that contributes to neuroinflammation and neuronal
dysfunction underlying PSCID. We propose to conduct single-cell RNAseq (scRNAseq) and single-cell mass
cytometry (scCyTOF) of pericytes isolated from male and female, diabetic and no-diabetic NG2-DsRed mice,
which label pericytes in red, at 1 day (when pericytes are still attached to capillaries) and 7 days after stroke
(when pericytes are activated and detached from capillaries). Single-cell RNAseq will provide new information
on pericyte heterogeneity after stroke under diabetic and non-diabetic conditions (on a spectrum ranging from
quiescent, capillary attached pericytes to activated, migrating and proliferating pericytes). Furthermore,
differential gene expression analysis of pericyte subpopulations from diabetic and non-diabetic brains will provide
insight into the role of pericyte heterogeneity in recovery from stroke and post-stroke dementia. We will confirm
RNAseq results and further phenotype pericyte subpopulations using scCyTOF.
抽象的
在当前补充填充完成的研究中提出的工作在父母Ninds R01 NS108501-中提出的工作
01“糖尿病中风中的内皮 - 肽串扰”。在父r01中的研究集中于急性
糖尿病性中风后常见的血管变化(即微血管无流量)。当前补充
将研究中风后的长期认知障碍,这在糖尿病后也更为常见
中风(冲程后认知障碍和痴呆,PSCID)。家长项目专门调查了
内皮 - 周期性信号传导的作用(内皮衍生的环氧树阳离子(EET)作用于GPR39上的Eets(EET)
糖尿病性中风后微血管无流量的细胞周期周期)。我们检验了以下假设
EET/CPR39串扰可保留缺血后大脑中毛细血管血流,糖尿病减少
微血管内皮EET,导致周细胞收缩和受伤以及随后的毛细血管阻塞
(无回流)。在研究过程中,我们观察到,在中风后的延迟阶段,
周细胞脱离毛细血管,扩散并远离毛细血管。我们还观察到
这些周细胞经历与周细胞激活一致的形态转化。活性
据报道,周细胞在不同疾病下发挥促炎和抗炎作用
状况。但是,周细胞激活在中风恢复的慢性阶段和后
糖尿病状况下的中风认知障碍尚不清楚。我们将测试以下假设
大脑,周细胞激活可促进中风后的恢复和功能修复。在糖尿病状况下,
活化的周细胞切换到有助于神经炎症和神经元的促炎表型
PSCID的功能障碍。我们建议进行单细胞RNASEQ(SCRNASEQ)和单细胞质量
从男性和女性,糖尿病和无糖尿病NG2-DSRED小鼠分离的周细胞的细胞仪(SCCYTOF),
在1天(毛细管附着周细胞时)和中风后7天,哪个标记为红色
(激活周细胞并与毛细血管脱离时)。单细胞RNASEQ将提供新信息
在糖尿病和非糖尿病状况下中风后的周细胞异质性(在光谱上
静止的,毛细管附着于活化,迁移和增殖的周细胞)。此外,
糖尿病和非糖尿病大脑的周细胞亚群的差异基因表达分析将提供
深入了解周细胞异质性在中风和中风后痴呆中恢复中的作用。我们将确认
RNASEQ使用SCCYTOF结果和进一步的表型细节亚群。
项目成果
期刊论文数量(17)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Role of GPR39 in Neurovascular Homeostasis and Disease.
- DOI:10.3390/ijms22158200
- 发表时间:2021-07-30
- 期刊:
- 影响因子:5.6
- 作者:Xu Y;Barnes AP;Alkayed NJ
- 通讯作者:Alkayed NJ
Apolipoprotein E4 mediates insulin resistance-associated cerebrovascular dysfunction and the post-prandial response.
- DOI:10.1177/0271678x17746186
- 发表时间:2019-05
- 期刊:
- 影响因子:0
- 作者:Johnson LA;Torres ER;Weber Boutros S;Patel E;Akinyeke T;Alkayed NJ;Raber J
- 通讯作者:Raber J
GPR39 Deficiency Impairs Memory and Alters Oxylipins and Inflammatory Cytokines Without Affecting Cerebral Blood Flow in a High-Fat Diet Mouse Model of Cognitive Impairment.
- DOI:10.3389/fncel.2022.893030
- 发表时间:2022
- 期刊:
- 影响因子:5.3
- 作者:
- 通讯作者:
Vascular Biology.
- DOI:10.1161/strokeaha.121.033556
- 发表时间:2021-07
- 期刊:
- 影响因子:8.3
- 作者:Alkayed NJ;Cipolla MJ
- 通讯作者:Cipolla MJ
Age-dependent cognitive impairment, hydrocephalus and leukocyte infiltration in transgenic mice with endothelial expression of human EPHX2.
- DOI:10.1038/s41514-022-00090-1
- 发表时间:2022-07-05
- 期刊:
- 影响因子:0
- 作者:Davis, Catherine M;Zhang, Wenri H;Bah, Thierno M;Roese, Natalie E;Allen, Elyse M;Leung, Philberta;Boutros, Sydney J;Marzulla, Tessa;Patel, Esha;Nie, Xiao;Alkayed, Farah N;Huang, Justin H;Jensen, Michael A;Raber, Jacob;Pike, Martin M;Alkayed, Nabil J
- 通讯作者:Alkayed, Nabil J
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Nabil J Alkayed其他文献
Nabil J Alkayed的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Nabil J Alkayed', 18)}}的其他基金
GPR39 as a Therapeutic Target in Aging-Related Vascular Cognitive Impairment and Dementia
GPR39 作为衰老相关血管认知障碍和痴呆的治疗靶点
- 批准号:
10734713 - 财政年份:2023
- 资助金额:
$ 20.48万 - 项目类别:
Training in Translational Science and Cardiovascular Research
转化科学和心血管研究培训
- 批准号:
10711526 - 财政年份:2023
- 资助金额:
$ 20.48万 - 项目类别:
Soluble Epoxide Hydrolase Inhibitor GSK2256294 for Acute Ischemic Stroke
可溶性环氧化物水解酶抑制剂 GSK2256294 用于治疗急性缺血性中风
- 批准号:
10672750 - 财政年份:2023
- 资助金额:
$ 20.48万 - 项目类别:
GPR39 as a Therapeutic Target in Subarachnoid Hemorrhage (SAH)
GPR39 作为蛛网膜下腔出血 (SAH) 的治疗靶点
- 批准号:
10478533 - 财政年份:2022
- 资助金额:
$ 20.48万 - 项目类别:
Role of GPR39 in Aging-Related Vascular Cognitive Impairment (VCI)
GPR39 在衰老相关血管认知障碍 (VCI) 中的作用
- 批准号:
10538329 - 财政年份:2022
- 资助金额:
$ 20.48万 - 项目类别:
Pericyte phenotypic switching in diabetic post-stroke cognitive impairment (PSCI)
糖尿病中风后认知障碍(PSCI)中的周细胞表型转换
- 批准号:
10855709 - 财政年份:2018
- 资助金额:
$ 20.48万 - 项目类别:
Endothelial-Pericyte Crosstalk in Diabetic Stroke
糖尿病中风的内皮-周细胞串扰
- 批准号:
10338161 - 财政年份:2018
- 资助金额:
$ 20.48万 - 项目类别:
Neuroinflammatory Mechanisms of Vascular Cognitive Impairment
血管性认知障碍的神经炎症机制
- 批准号:
10753185 - 财政年份:2017
- 资助金额:
$ 20.48万 - 项目类别:
Neuroinflammatory mechanisms of aging-related vascular cognitive impairment (VCI)
衰老相关血管性认知障碍(VCI)的神经炎症机制
- 批准号:
9461247 - 财政年份:2017
- 资助金额:
$ 20.48万 - 项目类别:
DRα1-MOG: A Novel Immunomodulatory Therapeutic for Stroke
DRα1-MOG:一种新型中风免疫调节疗法
- 批准号:
9409245 - 财政年份:2017
- 资助金额:
$ 20.48万 - 项目类别:
相似国自然基金
靶向HDAC3/SIAH2蛋白复合物的HDAC3降解剂的作用机制、结构改造及非酶活功能介导的抗炎活性研究
- 批准号:
- 批准年份:2022
- 资助金额:30 万元
- 项目类别:青年科学基金项目
卡萨烷选择性调控糖皮质激素受体GR功能的抗炎作用机制与新颖调控剂的设计与发现
- 批准号:82273824
- 批准年份:2022
- 资助金额:52 万元
- 项目类别:面上项目
靶向HDAC3/SIAH2蛋白复合物的HDAC3降解剂的作用机制、结构改造及非酶活功能介导的抗炎活性研究
- 批准号:82204218
- 批准年份:2022
- 资助金额:30.00 万元
- 项目类别:青年科学基金项目
ZAP-70选择性共价抑制剂及降解剂的设计合成和抗炎活性研究
- 批准号:82103973
- 批准年份:2021
- 资助金额:24.00 万元
- 项目类别:青年科学基金项目
ZAP-70选择性共价抑制剂及降解剂的设计合成和抗炎活性研究
- 批准号:
- 批准年份:2021
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Role of Creatine Metabolism in Necrotizing Enterocolitis
肌酸代谢在坏死性小肠结肠炎中的作用
- 批准号:
10724729 - 财政年份:2023
- 资助金额:
$ 20.48万 - 项目类别:
Antiretroviral therapy adherence and exploratory proteomics in virally suppressed people with HIV and stroke
病毒抑制的艾滋病毒和中风患者的抗逆转录病毒治疗依从性和探索性蛋白质组学
- 批准号:
10748465 - 财政年份:2023
- 资助金额:
$ 20.48万 - 项目类别:
MRI Study of Hydrogen Water and Minocycline Combination Therapy for Ischemic Stroke
氢水与米诺环素联合治疗缺血性中风的MRI研究
- 批准号:
10564735 - 财政年份:2023
- 资助金额:
$ 20.48万 - 项目类别:
Central Nervous System Reprogramming of the Control of Blood Pressure Induced by Early Life Stress
早期生活压力引起的血压控制的中枢神经系统重新编程
- 批准号:
10555126 - 财政年份:2023
- 资助金额:
$ 20.48万 - 项目类别:
The protective function of blood-borne monocytes/macrophages after delayed recanalization in a permanent MCAO rodent model
永久性 MCAO 啮齿动物模型延迟再通后血源性单核细胞/巨噬细胞的保护功能
- 批准号:
10806832 - 财政年份:2023
- 资助金额:
$ 20.48万 - 项目类别: